Naik R B, Ashlin R, Wilson C, Smith D S, Lee H A, Slapak M
Clin Nephrol. 1979 May;11(5):245-50.
Plasmapheresis has been studied in ten patients who received cadaveric renal allografts. In six patients (group A), plasma was carried out on the first post-operative day and then on alternate days until six treatments had been completed. No beneficial effect was observed but treatment was well tolerated and there were no complications. One patient retains a functioning graft. Plasma exchange was carried out on six consecutive days in five patients (group B) who were actively rejecting their grafts and in whom conventional methods of treatment had failed. All five patients showed improvement in graft function. Rejection was reversed in four patients and was contained in one patient. Subsequently rapid recrudescence of graft rejection occurred in one patient, extended graft survival was seen in two patients, and the other two patients have retained life supporting grafts. Plasmapheresis may have a part to play in the treatment of renal allograft rejection and further evaluation of this treatment is indicated.
已对10例接受尸体肾移植的患者进行了血浆置换研究。在6例患者(A组)中,术后第一天进行了血浆置换,然后隔天进行,直至完成6次治疗。未观察到有益效果,但治疗耐受性良好,且无并发症。1例患者移植肾仍有功能。对5例移植肾正在发生急性排斥且传统治疗方法无效的患者(B组)连续6天进行了血浆置换。所有5例患者的移植肾功能均有改善。4例患者的排斥反应得到逆转,1例患者的排斥反应得到控制。随后,1例患者移植肾排斥反应迅速复发,2例患者移植肾存活期延长,另外2例患者依靠移植肾维持生命。血浆置换在肾移植排斥反应的治疗中可能发挥一定作用,有必要对该治疗方法作进一步评估。